1,247
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Oral and Topical Administration of a Standardized Saw Palmetto Oil Reduces Hair Fall and Improves the Hair Growth in Androgenetic Alopecia Subjects – A 16-Week Randomized, Placebo-Controlled Study

ORCID Icon, , , , &
Pages 3251-3266 | Received 16 Aug 2023, Accepted 24 Oct 2023, Published online: 11 Nov 2023

References

  • English RS. A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors. Med Hypotheses. 2018;111:73–81. doi:10.1016/j.mehy.2017.12.027
  • Lolli F, Pallotti F, Rossi A, et al. Androgenetic alopecia: a review. Endocrine. 2017;57:9–17. doi:10.1007/s12020-017-1280-y
  • York K, Meah N, Bhoyrul B, Sinclair R. A review of the treatment of male pattern hair loss. Expert Opin Pharmacother. 2020;21(5):603–612. doi:10.1080/14656566.2020.1721463
  • Kranz D. Young men’s coping with androgenetic alopecia: acceptance counts when hair gets thinner. Body Image. 2011;8(4):343–348. doi:10.1016/j.bodyim.2011.06.006
  • Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136–141.e135. doi:10.1016/j.jaad.2017.02.054
  • Triyangkulsri K, Suchonwanit P. Role of Janus kinase inhibitors in the treatment of alopecia areata. Drug Des Devel Ther. 2018;12:2323–2335. doi:10.2147/DDDT.S172638
  • Fertig R, Tosti A. Frontal fibrosing alopecia treatment options. Intractable Rare Dis Res. 2016;5(4):314–315. doi:10.5582/irdr.2016.01065
  • Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777–2786. doi:10.2147/DDDT.S214907
  • van Zuuren EJ, Fedorowicz Z. Interventions for female pattern hair loss. JAMA Dermatol. 2017;153(3):329–330. doi:10.1001/jamadermatol.2016.5790
  • Hirshburg JM, Kelsey PA, Therrien CA, Gavino AC, Reichenberg JS. Adverse effects and safety of 5-alpha reductase inhibitors (Finasteride, Dutasteride): a systematic review. J Clin Aesthet Dermatol. 2016;9(7):56–62.
  • Abe M, Ito Y, Suzuki A, Onoue S, Noguchi H, Yamada S. Isolation and pharmacological characterization of fatty acids from saw palmetto extract. Anal Sci. 2009;25:553‐557. doi:10.2116/analsci.25.553
  • Patel S, Sharma V, Chauhan N, et al. Hair growth: focus on herbal therapeutic agent. Curr Drug Discov Technol. 2015;12:21‐42. doi:10.2174/1570163812666150610115055
  • Pais P, Villar A, Rull S. Determination of the potency of a novel saw palmetto supercritical CO2 extract (SPSE) for 5α-reductase isoform II inhibition using a cell-free in vitro test system. Res Rep Urol. 2016;8:41–49. doi:10.2147/RRU.S96576
  • Kwon Y. Use of saw palmetto (Serenoa repens) extract for benign prostatic hyperplasia. Food Sci Biotechnol. 2019;28(6):1599–1606. doi:10.1007/s10068-019-00605-9
  • Narda M, Aladren S, Cestone E, Nobile V. Efficacy and safety of a food supplement containing L-cystine, Serenoa repens extract and biotin for hair loss in healthy males and females. a prospective, randomized, double-blinded, controlled clinical trial. J Cosmo Trichol. 2017;3:127. doi:10.4172/2471-9323.1000127
  • Gómez Grau E, Lladós Sevilla M, Mira J, Vivancos F. Efficacy of a food supplement with Serenoa serrulata and tocotrienol-tocopherol against androgenetic alopecia and female telogen effluvium: about a pilot study. Rev. Argent Dermatol. 2015;96(1):43–55.
  • Wessagowit V, Tangjaturonrusamee C, Kootiratrakarn T, et al. Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract. Australas J Dermatol. 2016;57(3):e76–82. doi:10.1111/ajd.12352
  • Sudeep HV, Venkatakrishna K, Amrutharaj B, Shyamprasad K, Shyamprasad K. A phytosterol-enriched saw palmetto supercritical CO2 extract ameliorates testosterone-induced benign prostatic hyperplasia by regulating the inflammatory and apoptotic proteins in a rat model. BMC Complement Altern Med. 2019;19(1):270. doi:10.1186/s12906-019-2697-z
  • Sudeep HV, Thomas JV, Shyamprasad K. A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiency. BMC Urol. 2020;20(1):86. doi:10.1186/s12894-020-00648-9
  • Wasko CA, Mackley CL, Sperling LC, Mauger D, Miller JJ. Standardizing the 60-second hair count. Arch Dermatol. 2008;144:759–762. doi:10.1001/archderm.144.6.759
  • Dhurat R, Saraogi P. Hair evaluation methods: merits and demerits. Int J Trichology. 2009;1(2):108–119. doi:10.4103/0974-7753.58553
  • Gubelin Harcha W, Barboza Martínez J, Tsai TF, et al. A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia. J Am Acad Dermatol. 2014;70(3):489–498.e3. doi:10.1016/j.jaad.2013.10.049
  • Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride male pattern hair loss study group. J Am Acad Dermatol. 1998;39(4 Pt 1):578–589. doi:10.1016/S0190-9622(98)70007-6
  • Zanzottera F, Bizzaro G, Michelotti A, Nobile V. Efficacy of a nutritional supplement, standardized in fatty acids and phytosterols, on hair loss and hair health in both women and men. J Cosmo Trichol. 2017;3(121):2. doi:10.4172/2471-9323.1000121
  • Farris PK, Rogers N, McMichael A, Kogan S. A novel multi-targeting approach to treating hair loss, using standardized nutraceuticals. J Drugs Dermatol. 2017;16(11):S141–8.
  • Pezza M, Carlomagno V, Casucci G. Telogen effluvium treated with Serenoa repens supplement. J Senses Sci. 2014;1:1.
  • Abe M, Ito Y, Oyunzul L, Oki-Fujino T, Yamada S. Pharmacologically relevant receptor binding characteristics and 5 alpha-reductase inhibitory activity of free fatty acids contained in saw palmetto extract. Biol Pharm Bull. 2009;32(4):646–650. doi:10.1248/bpb.32.646
  • Cabeza M, Bratoeff E, Heuze I, Ramirez E, Sanchez M, Flores E. Effect of beta-sitosterol as inhibitor of 5 alpha-reductase in hamster prostate. Proc. West Pharmacol Soc. 2003;46:153–155.
  • Caserini M, Radicioni M, Leuratti C, Terragni E, Iorizzo M, Palmieri R. Effects of a novel finasteride 0.25% topical solution on scalp and serum dihydrotestosterone in healthy men with androgenetic alopecia. Int. J Clin Pharmacol Ther. 2016;54(1):19–27.
  • Piraccini BM, Blume-Peytavi U, Scarci F, et al. Topical finasteride study group. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a Phase III, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol. 2022;36(2):286–294. doi:10.1111/jdv.17738
  • Irwig MS, Kolukula S. Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med. 2011;8:1747–1753. doi:10.1111/j.1743-6109.2011.02255.x
  • Oliveira-Soares R, André MC, Peres-Correia M. Adverse effects with finasteride 5 mg/day for patterned hair loss in premenopausal women. Int J Trichology. 2018;10(1):48–50. doi:10.4103/ijt.ijt_73_15
  • Agbabiaka TB, Pittler MH, Wider B, Ernst E. Serenoa repens (saw palmetto): a systematic review of adverse events. Drug Saf. 2009;32(8):637–647. doi:10.2165/00002018-200932080-00003
  • Zhu HL, Gao YH, Yang JQ, Li JB, Gao J. Serenoa repens extracts promote hair regeneration and repair of hair loss mouse models by activating TGF-β and mitochondrial signaling pathway. Eur Rev Med Pharmacol Sci. 2018;22(12):4000–4008.
  • Chittur S, Parr B, Marcovici G. Inhibition of inflammatory gene expression in keratinocytes using a composition containing carnitine, thioctic acid and saw palmetto extract. Evid Based Complement Alternat Med. 2011;2011(985345):1–7. doi:10.1093/ecam/nep102
  • Choi S, Kim KW, Choi JS, et al. Angiogenic activity of beta-sitosterol in the ischaemia/reperfusion-damaged brain of Mongolian gerbil. Planta Med. 2002;68(4):330–335. doi:10.1055/s-2002-26750